Nov 24 Indivior Plc said on Tuesday the U.S. Food and Drug Administration rejected its nasal spray for the emergency treatment of opioid overdose.
These sprays contain naloxone, a drug that has been used to treat opioid overdose for nearly 45 years in injectable forms.
22:31 Making America great again apparently includes Cold War-era nuclear dominance17
16:51 Mexico to extradite cocaine cartel member 'El Gordo' to U.S16
19:44 Shadow president or mere shadow? In Europe, Pence seeks to reassure allies unnerved by Trump14
00:02 Omar Abdel Rahman, imprisoned ‘blind sheikh’ linked to terrorist efforts, dies at 7823